| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |